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1. INTRODUCTION 
Cancer, in medicine, common term for neoplasms, or tumors, that are malignant. Like benign 
tumors, malignant tumors do not respond to body mechanisms that limit cell growth. Unlike 
benign tumors, malignant tumors consist of differentiated, or unspecialized, cells that show 
an atypical cell structure and do not function like the normal cells from the organ from which 
they derive. Cancer is the major disorder, which increases morbidity and mortality in both 
male and females1,2 
Causes of Cancer 
Fig 1. Percentage of cancer causes by different factors 
 
Causes of Cancer 
Certain genes control the life cycle – the growth, function, division, and death -- of a cell. 
When these genes are damaged, the balance between normal cell growth and death is lost. 
Cancer occurs due to DNA damage and out-of-control cell growth. The following is a partial 
list of factors known to damage DNA and increase the risk of cancer: 
 
\ 
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 Genetic mutations (for example, BRCA1 and BRCA2) 
 Environmental exposure to UV radiation, air pollution 
 Bacterial (H. pylori) and viral infections (Epstein-Barr, HPV, hepatitis B and C) 
 Lifestyle choices (poor diet, inactivity, obesity, heavy alcohol use, smoking cigarettes 
and tobacco use, exposure to chemicals and toxins) 
 Treatment with chemotherapy, radiation, or immunosuppressive drugs. 3,4 
Gene Mutation 
Cancer is caused by changes (mutations) to the DNA within cells. The DNA inside a cell is 
packaged into a large number of individual genes, each of which contains a set of instructions 
telling the cell what functions to perform, as well as how to grow and divide. Errors in the 
instructions can cause the cell to stop its normal function and may allow a cell to become 
cancerous. 
Effects of gene mutations  
A gene mutation can instruct a healthy cell to allow rapid growth. A gene mutation can tell a 
cell to grow and divide more rapidly. This creates many new cells that all have that same 
mutation. 
1. Failure to stop uncontrolled cell growth.  
2. Normal cellsknow when to stop growing so that you have just the right number of each 
type of cell. Cancer cells lose the controls (tumor suppressor genes) that tell them when to 
stop growing. A mutation in a tumor suppressor gene allows cancer cells to continue 
growing and accumulating. 
3. Make mistakes when repairing DNA errors. DNA repair genes look for errors in a cell's 
DNA and make corrections. A mutation in a DNA repair gene may mean that other errors 
aren't corrected, leading cells to become cancerous. 
These mutations are the most common ones found in cancer. But many other gene mutations 
can contribute to causing cancer. 
 
 
 
Introduction 
 
Department Of Pharmaceutical Chemistry ,MMC  Page 3 
 
Causes gene mutations 
Gene mutations can occur for several reasons, for instance: 
Gene mutations you're born with. You may be born with a genetic mutation that you inherited 
from your parents. This type of mutation accounts for a small percentage of cancers. 
Gene mutations that occur after birth. Most gene mutations occur after you're born and aren't 
inherited. A number of forces can cause gene mutations, such as smoking, radiation, viruses, 
cancer causing chemicals (carcinogens), obesity, hormones, chronic inflammation and a lack 
of exercise. 
Gene mutations occur frequently during normal cell growth. However, cells contain a 
mechanism that recognizes when a mistake occurs and repairs the mistake. Occasionally, a 
mistake is missed. This could cause a cell to become cancerous.5,6 
Symptoms of Cancer 
Signs and symptoms caused by cancer will vary depending on what part of the body is 
affected.4 
Some general signs and symptoms associated with, but not specific to, cancer, include: 
 Fatigue 
 Lump or area of thickening that can be felt under the skin 
 Weight changes, including unintended loss or gain 
 Skin changes, such as yellowing, darkening or redness of the skin, sores that won't 
heal, or changes to existing moles 
 Changes in bowel or bladder habits 
 Persistent cough or trouble breathing 
 Difficulty swallowing 
 Hoarseness 
 Persistent indigestion or discomfort after eating 
 Persistent, unexplained muscle or joint pain 
 Persistent, unexplained fevers or night sweats 
 Unexplained bleeding or bruising 
Introduction 
 
Department Of Pharmaceutical Chemistry ,MMC  Page 4 
 
Types of Cancer 
Fig 2. Benign Vs. Malignant Tumors 
 
Tumors: Benign vs. Malignant 
A tumor is an abnormal mass of cells. Tumors can either be benign (non-cancerous) or 
malignant (cancerous). Benign tumors grow locally and do not spread. Malignant tumors 
have the ability to spread and invade other tissues. This process, which is a key feature of 
cancer, is known as metastasis. 
Types of Cancer 
There are over 200 types of cancer. However, the NCI lists several general categories . It is 
not all inclusive and the cancers listed in quotes are the general names of some cancers: 
Carcinoma: Cancer that begins in the skin or in tissues that line or cover internal organs -- 
"skin, lung, colon, pancreatic, ovarian cancers," epithelial, squamous and basal cell 
carcinomas, melanomas, papillomas, and adenomas. 
 
Sarcoma: Cancer that begins in bone, cartilage, fat, muscle, blood vessels, or other 
connective or supportive tissue -- "bone, soft tissue cancers," osteosarcoma, synovial 
sarcoma, liposarcoma, angiosarcoma, rhabdosarcoma, and fibrosarcoma. 
Leukemia: Cancer that starts in blood-forming tissue such as the bone marrow and causes 
large numbers of abnormal blood cells to be produced and enter the blood -- "leukemia," 
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lymphoblastic leukemias (ALL and CLL), myelogenousleukemias (AML and CML), T-cell 
leukemia, and hairy-cell leukemia. 
 Lymphoma and myeloma: Cancers that begin in the cells of the immune system -- 
"lymphoma," T-cell lymphomas, B-cell lymphomas, Hodgkin lymphomas, non-Hodgkin 
lymphoma, and lymphoproliferative lymphomas 
Central nervous system cancers: Cancers that begin in the tissues of the brain and spinal 
cord -- "brain and spinal cord tumors," gliomas, meningiomas, pituitary adenomas, vestibular 
schwannomas, primary CNS lymphomas, and primitive neuroectodermal tumors.7 
Metastasis 
Metastasis is the process whereby cancer cells break free from a tumor and travel to and 
invade other tissues in the body. Cancer cells metastasize to other sites via the lymphatic 
system and the bloodstream. Cancer cells from the original -- or primary -- tumor can travel 
to other sites such as the lungs, bones, liver, brain, and other areas. These metastatic tumors 
are "secondary cancers" because they arise from the primary tumor. 
Metastatic cancer retains the name of the primary cancer. For example, bladder cancer that 
metastasizes to the liver is not liver cancer. It is called metastatic bladder cancer. Metastasis 
is significant because it helps determine the staging and treatment of cancer. Some types of 
metastatic cancer are curable, but many are not. 
 
Fig 3. Example of primary cancer metastasize 
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Not included in the above types listed are metastatic cancers; this is because metastatic cancer 
cells usually arise from a cell type listed above and the major difference from the above types 
is that these cells are now present in a tissue from which the cancer cells did not originally 
develop. Consequently, if the terms "metastatic cancer" is used, for accuracy, the tissue from 
which the cancer cells arose should be included. For example, a patient may say they have or 
are diagnosed with "metastatic cancer" but the more accurate statement is "metastatic (breast, 
lung, colon, or other type) cancer with spread to the organ in which it has been found.8,9 
Cancer - Indian scenario 
Every year about 8, 50,000 new cancer cases being diagnosed, India resulting about 5, 80,000 
cancers related death every year. India had the highest number of the oral and throat cancer 
cases in the world. Every third oral cancer patient in the world is from India. In males Oral, 
Lungs and Stomach cancers was the three most common causes of cancer incidence and 
death whereas In females Cervical, Breast and Oral cancers were the three main causes of 
cancer related illnesses and death.  
Overall cervical cancer was the number one cause of cancer death in India. That was really 
unfortunate as cervical cancer can be easily prevented and also relatively easy to diagnose 
and treat at an early stage. Compared to developed countries overall there were less cancer 
cases in India but that could be due to under diagnosis and under reporting. At the same time 
regional, ethnic, dietary and socio-economic factors might also results in difference in the 
cancer susceptibilities and the incidence. Also cancer was mainly a disease of old ages. 
Worldwide median age at diagnosis was about 60 years. Average life span was about 58 yrs 
in India comparedto 75 yrs in the developed world. 
Cancer- global scenario 
Among all the cancer, Lung cancer is the most common worldwide and accounts for major 
deathannually. The three leading cancer killers were different than the three most common 
forms, (i) Lung cancer responsible for 17.8 per cent of all cancer deaths. (ii) Stomach 10.4 
per cent and (iii) Liver 8.8 percent. Industrial nations with the highest overall cancer rates 
include: U.S.A, Italy, Australia, Germany, The Netherlands, Canada and France. Developing 
countries with the lowest cancer were in Northern Africa. Cancer rates could further increase 
by 50% to 15 million new cases in the year 2020.According to the World Cancer Report, the 
most comprehensive global examination of the disease to date. However, the report also 
provides clear evidence that healthy lifestyles, and publichealth action by governments and 
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Radiation therapyeither from an external beam or from implanted radioactive pellets—is the 
primary treatment. The usual forms are X rays and gamma rays. Use of radioactive elements 
specific for particular target organs, such as radioactive iodine specific for the thyroid gland, 
is effective in treating malignancies of those organs. 
Cytotoxic chemotherapy is used as a primary treatment for some cancers, such as 
lymphomas and leukemias or as an addition to surgery or radiation therapy. Cytotoxic drugs 
(drugs that are toxic to cells) are aimed at rapidly proliferating cells and interfere with nucleic 
acid and protein synthesis in the cancer cell, but they are often toxic to normal rapidly 
proliferating cells, such as bone marrow and hair cells.  
Hormonal chemotherapyIs based upon the fact that the growth of some malignant tumors 
(specifically those of the reproductive organs) is influenced by reproductive hormones. 
Tamoxifen is a naturally occurring estrogen inhibitor used to prevent breast cancer 
recurrences. Flutamide is sometimes used in prostate cancer to inhibit androgen uptake. Sex-
hormone related drugs such as DES and tamoxifen, which may be carcinogenic under some 
conditions, have proven to be protective under others. 
Immunotherapy (sometimes called biological therapy) uses substances that help the body 
mobilize its immune defenses. Some attack the tumor itself, while others bolster the body's 
ability to withstand conventional chemotherapy treatment. Other new or experimental 
therapies include drugs that inhibit angiogenesis and photodynamic therapy, in which a 
patient is given a drug to make the tumor light-sensitive, after which the tumor is exposed to 
bright laser light.11 
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Phytochemical importance of medicinal plants as potential sources of 
anticancer agents 
The potential medicinalproperties of plant species have contributed significantly in the 
development of various herbal therapies for a number of diseases acrossthe globe. The 
benefits of herbal medicine over allopathic medicine have helped medicinal plants to regain 
their importance in the fieldof health and medicine. Cancer is one of the major health 
problems that have widely affected the world’s population. There is a greatneed to combat 
this disease with better and more effective medication as compared to existing therapies. A 
vast number of medicinalplants are known to have biochemical constituents with anticancer 
properties. The chemical metabolites of natural origin that possessanticancer properties can 
serveas potential lead compounds in drug designing. This association of medicinal plants and 
cancer needsfurther research and experimentation in order to develop and design anticancer 
drugs. 
Thevast array of therapeutic effects associated with medicinal plants includes anti-
inflammatory, antiviral, antitumor,antimalarial, and analgesic. Cancer is one of the 
majorobstacles to human health around the world. Among allepidemic diseases, cancer holds 
the first place as a deathcausingdisease. The main reason behind the growingnumber of 
cancer cases is the changing lifestyle of thepopulation across the globe. Keeping in view the 
statisticaldata, the most prevalent cancer among females is breastcancer, accounting for about 
23% of total cancer cases; inmales, the most prevalent is lung cancer, which accountsfor 17% 
of total cancer cases12. Poorsurvival rate of cancer patients in developing countriesis 
attributed to the lack of timely diagnosis and limitedtreatment facilities. There is a great need 
to address thisepidemic disease with more effective therapeutic andpreventive strategies, 
which could be possible with the useof natural compounds.Recently the scientific world has 
experienced anupsurge of interest in the therapeutic potential of medicinalplants as a source 
of promising anticancer agents. However,the application of plant-based compounds for the 
treatmentof cancer can be traced back to 1950s. Some of the very firstanticancer agents 
derived from plants are vinca alkaloids,vinblastine, vincristine, and cytotoxic 
podophyllotoxins.Statistical data suggest that 16 plant-derived anticancer drugshave been 
subjected to clinical trials so far 13. Landmarks of these clinical trials are flavopiridol,isolated 
from the Indian tree Dysoxylumbinectariferum,andmeisoindigo, isolated from the Chinese 
plant Indigoferatinctoria, which have been documented to have less toxicitythan 
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conventional chemotherapeutic anticancer drugs.14 These discoveries have propelledthe 
scientific interest of various research groups in thediscovery of new anticancer agents from 
all-natural productsources, inclusive of plant secondary metabolites. Theemerging importance 
of natural anticancer agents demandsmore research and experimentation in order to 
developsuccessful natural therapeutic options for this disease. 
 
Medicinal plants as the best choice for cancer treatment 
The chemical components of medicinal plants mainly possess antioxidant properties that 
contribute to their anticancer potential. Flavones, isoflavones, flavonoids, anthocyanins, 
coumarins, lignans, catechins, andisocatechins are the major classes of bioactive constituents 
responsible for the antioxidant action.15 The great potential of plant-based compounds for the 
treatment and prevention of cancer is attributed totheir safety, low cost, and oral 
bioavailability. The already available expensive conventional therapies for cancer like 
chemotherapy and radiotherapy have a number of side effects such as myelosuppression and 
neurological, cardiac, pulmonary, and renal toxicity, which pose serious harm to the quality 
of life.16 
 
Flavonoids 
Flavonoids may act at the different development stages of malignant tumors by protecting 
DNA against oxidative damage, inactivating carcinogens, inhibiting the expression of the 
mutagenic genes and enzymes responsible for activating procarcinogenic substances, and 
activating the systems responsible for xenobiotic detoxification.17 
Although most flavonoids appear to be nontoxic to humans and animals, they have been 
demonstrated to inhibit proliferation in many kinds of cancerous cell lines. For instance, it 
has been reported that flavonoids (quercetin and taxifolin) have anti-proliferative effects on 
squamous cell carcinoma HTB43.18Quercetin at 10 μM shows an anti-proliferative activity 
against  meningioma cells 19 and against colon cancer cells (Caco-2 and HT-29), with a dose- 
ependent effect.20Diosmin, another important Citrus flavonoid, which is on the market as a 
venotonic, has shown anti-proliferative activity in Caco-2 and HT-29 colon cancer cell lines 
(IC50 203 μM), although with less efficacy than quercetin.21 
Therefore, there is a need to develop treatment options that include more potent and less toxic 
anticancer drugs as compared to existing drugs. The market statistics mark the availability of 
approximately 60% plant-based anticancer drugs.22 Medicinal plants constitute a common 
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alternative to cancer treatment in many countries of the world.23,24 Cytotoxic screening of a 
number of plants has been done to correlate their anticancer activity and further expand their 
scope for drug development.25Owing to potential benefits of plantbased drugs for cancer 
treatment, their use is increasingly growing from 10% to 40% across the globe; specifically, 
on the Asian continent, it has reached 50%. Anticancer benefits associated with natural plant 
derivatives demand extensive scientific screening and clinical experimentations for 
thedevelopment of improved drugs.26,27 
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2.REVIEW OF LITERATURE 
 Pharmacological Review 
1. Sergio Granados et al., (2015) reported a bio guided assay, a crude extract stimulated 
glucose uptake in C2C12 myotubes up to 30%, thereby reducing insulin resistance induced 
by fatty acids compared to the basal control. A chromatographic fraction applied 
intraperitoneally (IP) in mice reduced glucose by 42% in a mouse model of T2DM, after 
administration of 10 doses during 20 days. A flavanone was purified from this active 
fraction and its structure was assigned by 1H- and 13C-NMR (1D and 2D) and MS. This 
compound retains the previously reported activity, stimulating in vitro the glucose uptake in 
a concentration-dependent manner.28 
 
2. Murugalakshmi et al., (2014) investigated purgative activities of ethyl alcohol and acetone 
extracts using albino rats of both the sexes. The phytochemicalscreening of ethanoic 
extracts of Jatropha gossypiifolia leaves showsthe presence secondary metabolites such as 
Saponin, Tannins, Phenols, Steroids, Glycosides,Flavonoids etc., The ethanoic and acetone 
extract of Jatropha gossypiifolia have significantantipyretic activity and purgative 
activity.29 
 
3. Juliana Félix-Silva et al., (2014) reported a review article, onup-to-date overview of the 
traditional uses, as well as the phytochemistry, pharmacology, and toxicity data of J. 
gossypiifolia species, in view of discussing its medicinal value and potential application in 
complementary and alternative medicine. Pharmacological studies have demonstrated 
significant action of different extracts and/or isolated compounds as antimicrobial, anti-
inflammatory, antidiarrheal, antihypertensive, and anticancer agents, among others, 
supporting some of its popular uses.Toxicological studies associated with phytochemical 
analysis are important to understand the eventual toxic effects that could reduce its 
medicinal value.30 
 
4. VidhyaKumari and Shikha Roy (2014) investigated the antibacterial activity of crude 
chloroform, methanolic and aqueous extracts of  Jatropha gossypiifolia L stem and leaves 
was investigated using disc agar diffusion against clinical isolates of bacteria consisting of 
 Bacillus  subtilis,  Escheria coli and  Pseudomonas putida  Jatrophagossypiifolia L well 
known plant of family Euphorbiaceae is used as a therapeutic agent. Crude powder of stem 
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and leaves screened for antibacterial activity by zone of inhibition. The extracts exhibited 
broad spectrum activities against microorganisms.31 
 
5. YerramsettyNagaharika et al., (2013) evaluated the anti-inflammatory activity of aqueous 
and alcoholic extract of J. gossypiifolia leaves by in vitro HRBC membrane stabilization 
method. The in vitro method showed significant anti-inflammatory property of different 
extracts tested. The aqueous extract at a concentration of 200g/mL showed significant 
activity when compared with the standard drug diclofenac sodium.32 
 
6. ApurbaSarkerApu et al., (2013)Solanumsisymbriifolium (Solanaceae) and 
Jatrophagossypiifolia (Euphorbiaceae) were evaluated for cytotoxic activity. Methanol 
crude extract and fractions of the extract of leaves of Jatropha gossypiifolia exhibited 
significant toxicity against the shrimps (LC50 values 17.19 – 98.19 μg/ml), while that of 
potassium permanganate, a positive control, was 11.27 μg/ml. Among the fractions of the 
crude extracts of both plants, non-polar fractions such as n-hexane, chloroform, 
dichloromethane were the most cytotoxic.33 
 
7. Olabinri BM Oladele AP et al., (2013) reported the influence of season , solvent type and 
concentration on the phenolic and flavonoid contents including in vitro antioxidant and 
nitric oxide radical scavenging activities of stem bark and leaf extracts of fignut 
(Jatrophagossypiifolia ) were investigated. Season, extraction solvent type and 
concentration were critical determinants of the total phenolic and flavonoid contents 
including in vitro antioxidant and nitric oxide radical scavenging activities of the plant 
parts.34 
 
8. Apu et al., (2013) evaluated analgesic activity, measured by acetic acid induced writhing 
inhibition test. The neuropharmacological activities were evaluated by hole cross, hole-
board, and elevated plus-maze (EPM) tests and the anti-diarrheal activity was assessed by 
castor oil induced diarrhea inhibition method.35 
 
9. Harneet Singh and Surendra Kr. Sharma (2013)evaluated the hypoglycemic effect of 
successive extracts of the roots of the plant in comparison to metformin. Petroleum ether 
(60-80° C), chloroform, methanol and aqueous extracts (250 and 500 mg/kg body weight) 
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were orally administered to alloxan induced diabetic mice for 7 days. Change in body 
weight and plasma glucose levels were estimated after the treatment.36 
 
10. Vishnu Sharma et al., (2013) examined the antibacterial activity of aqueous and ethanol 
extract of J. gossypiifolia using the disc diffusion method. Extracts were tested against both 
Gram positive (Bacillus subtilis MTCC 441 and Staphylococcus aureus MTCC 3381) and 
Gram negative (Escherichia coli MTCC 1562 and Pseudomonas fragi MTCC 2458) 
bacteria.37 
 
11. Pratibha Singh et al .,(2012) elucidated the possible toxic effects and mortality caused by 
crude latex and compound apigenin isolated from leaves of J. gossypiifolia on freshwater 
snakehead fish, Channapunctatus and Swiss albino mice Mus musculus.38 
 
12. Khumrungsee Net al (2011) evaluated the insecticidal effects of Thai botanical, senescent 
leaf Jatropha gossypiifolia extracts on second instar Spodopteraexigua larvae by the 
dipping method and topical sprayer method. The leaf crude extract was extracted using 
Soxhlet apparatus with ethyl acetate as solvent. The result shows 60 percent mortality of 
this parasite species at dose up to 40,000 ppm. Thus, Jatropha gossypiifolia leaf crude 
extracts can be as alternative IPM control tool for Spodopteraexigua which friendly to 
benefit insect such as Meteorus pulchricornis.39 
 
13. Datta A Dhale et al; (2010) reported antimicrobial effect of Jatropha gossypiifolia Linn. 
(Euphorbiaceae) leaf extract was evaluated on microbial strains like gram-positive species 
staphylococcus spp., and Bacillus spp. and gram-negative species Echerichia Spp. and 
Pseudomonas spp. The solvent used for extraction of plant were Petroleum ether, Alcohol, 
Chloroform. The alcoholic extract of leaves of Jatropha gossypiifolia shows maximum 
antimicrobial activity. The in vitro antimicrobial valuation was carried out by agar disc 
antimicrobial and preliminary phytochemical studies of Jatropha gossypiifoliawere also 
performed.40 
 
14. B.B. Panda et al., (2009) investigated hepatoprotective activity in carbon tetrachloride 
induced liver damage in Wister albino rats in the aerial part of Jatropha gossypiifolia. The 
extracts at dose of 200mg/kg were administered orally once daily. The substantially 
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elevated serum enzymatic levels of serum glutamate oxaloacetate transaminase (SGOT), 
serum glutamate pyruvate transaminase (SGPT), serum alkaline phosphatase (ALP), total 
bilirubin, SOD and catalase were restored towards normalization significantly by the 
extracts.41 
 
15. Taofeqoduola et al., (2005) evaluated the anticoagulant for biochemical and hematological 
analyses. The anticoagulant effect of the extract was found to be highest at a concentration 
of 0.1 ml per ml of blood. Blood tubes with dried leaf extract at the stated concentration 
were used for obtaining plasma. Mean plasma glucose values obtained from fluoride 
oxalate plasma were compared with values obtained from dried leaf extract plasma. The 
values obtained for biochemical parameters with the exception of bicarbonate from the leaf 
extract plasma samples were significantly higher (P<0.05) than values obtained from 
conventional anticoagulants.42 
 
. 
Phytochemical Review 
 
1. Nazeema.T.H,Girija.S et al., 2013Evaluated  the  cytotoxicity  of  Jatrophacurcus and 
Jatrophagossypiifolia on  HeLa  cell  lines  and  also  to  isolate  and characterize  the active  
principle  having  highest  anticancer  activity  in  the  methanolic  and  ethanoic  extract  of 
Jatrophacurcus  and  Jatrophagossypiifolia. Crude methanolic and ethanoic fractions of 
Jatrophacurcus and Jatrophagossypiifolia stem were examined for their anticancer activity. 
The anticancer activity was determined for different concentrations of the crude extract on 
HeLa cancer cell line by (MTT) assay. The extracts were then subjected to high 
performance liquid chromatography LC Column: Reverse Phase C 18 was used with a 
detection range of 254 nm.43 
 
2. Qiu Sheng – Xiang et al; (2011) evaluated phytochemistry anticancer activity of J. 
gossypiifolia root extract. Phytochemical investigation of the root of J. gossypiifolia 
resulted in the isolation and characterization of one new diterpenoid along with four well-
known compounds. The new compound was established by 1D and 2D NMR spectra and x-
ray analysis, while spectral (1H, 13C NMR, and ESI-MS) characteristics of the known 
compounds were compared with reported data. The new compound showed potent 
proliferation inhibitory activity against A-549 human cancer cell line.44 
Review Of Literature 
 
Department Of Pharmaceutical Chemistry ,MMC  Page 16 
 
 
3. Khyade MS et al; (2011) evaluated pharmacognostical and phytochemical on leaves of 
Jatropha gossypiifolia L. (Euphorbiaceae). Macromorphology, microscopy (transverse 
section, histochemicalcolor reactions and quantitative microscopy) and phytochemical 
components were studied to establish the salient diagnostic characters. WHO recommends 
physicochemical determination and phytochemical evaluation for quality control of 
medicinal plant materials. The various morphological, microscopical, physicochemical 
standards developed in this study will help for botanical identification and standardization 
of the drug in crude form.45 
 
4. A Falodun, TC Onwudiwe (2011) investigated the seed extract of Jatropha gossypiifolia 
was subjected to phytochemical and antimicrobial investigation using standard screening 
procedures. The phytochemical studies revealed the presence of some secondary 
metabolites such as alkaloids, saponins, tannins. There was no activity against the bacteria 
(Gram positive and negative organisms at 2.5-100mg/ml). The seed extract showed 
significant antifungal activity. The spectroscopic analysis (1D and 2DNMR) of the 
colorless oil gave 9-acetoxynerolidol. 46 
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3.PLANT PROFILE 
 
Fig 4.Jatropha gossypiifoliaL. 
 
Jatropha gossypiifolia 
L.Synonym: Adenoropiumgossypiifolium (L.) Pohl. 
Family: Euphorbiaceae47 
 
Vernacular Names 
Bengali/Vernacular Name: LalBheranda, Laljeol, Erenda.   
Tribal Name: Karachuni (Marma); Kander (Garo). 
English Name: Bellyache-bush. 
Hindi  Name : रतनजोतीRatanjoti 
Tamil Name :சிறியஆமணக்குSiriaAmanakku 
Other common names 
American purging nut,  black physic nut, black physicnut, cotton leaf physic nut, cotton-leaf 
jatropha, cotton-leaf physic nut, purging nut, red fig-nut flower, wild cassava 
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Habitat 
This species is most commonly found in drier tropical environments, but is sometimes also 
naturalised in sub-tropical and semi-arid regions. It is a weed of degraded pastures, open 
woodlands, monsoon vine forests, grasslands, riparian vegetation, coastal foreshores, 
roadsides, disturbed sites, waste areas and old or abandoned gardens. 
 
Distinguishing Features 
 Upright shrub or small tree usually growing 0.7-4 m tall. 
 Stems are thick and exude a soapy sap when broken. 
 Alternately arranged leaves have three or five pointed lobes and are dark reddish-purple 
when young. 
 Small flowers are dark red with yellow centers and are borne in clusters in the upper leaf 
forks. 
 Three-lobed fleshy capsules each contain three seeds. 
 
Chemical Constituents. 
 Leaves contain flavonoids, a saponin, a resin, tannin and triterpenes. They also 
contain flavonoids, vitexin, isovitexin and apigenin.  
 Roots contain antileukemic and tumour-inhibitor macrocyclicditerpene, jatrophone 
and jatropholones A and B Flavonoids. Bark contains β-sitosterol.  
 Roots, stems and seeds contain arylnaphthalenelignan and the lignanprasanthaline. 
Cyclogossine, a cyclic heptapeptide, had been isolated from the latex of the plant.  
 Stem contains a novel lignan, jatrodien48 
 Seeds contain fatty oil. 
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Ethnomedical Uses: 
 
           J. gossypiifolia is used for the treatment of various types of disorders in the ayurvedic 
and folklore system of medicine in Bangladesh.  
 The leaves of the plant are traditionally being applied to boils, carbuncles, eczema, 
itches, and venereal diseases in Latin America and the Caribbean and also used as 
febrifuge,bark is used as emmenagogue.49 
 Seeds are emetic, purgative and used for cancer and body pain. The leaves and seeds 
of J. gossypiifolia are considered as a purgative and are widely used to treat obstinate 
constipation. 50 
 Roots are used to treat leprosy and cancer and stem latex possess coagulant activity. 
To establish its traditional uses, J. gossypiifolia has been investigated for its anti-
allergic, molluscicidal, antimicrobial, insect repellent, Larvicidal, anti-feeding, 
coagulating, and anti-coagulating activities.51 
 One of the most well-known pharmacological activities of J. gossypiifolia is its 
antineoplastic action, which is frequently associated with the content of lignoids and 
terpenoids and flavonoids. The ethanoic extract from roots, as well as the isolated 
diterpenejatrophone, exhibited significant inhibitory activity in vitro against cells 
derived from human carcinoma of the nasopharynx and lymphocytic leukemia P-388 
and in vivo against four standard animal tumor systems, such as sarcoma 180, Lewis 
lung carcinoma, P-388 lymphocytic leukemia, and Walker 256 intramuscular 
carcinosarcoma.52 
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4. RATIONALE FOR SELECTION OF THE PLANT 
Jatropha gossypiifolia L. (Euphorbiaceae), widely known as “bellyache bush,” is a medicinal 
plant largely used throughout Africa and America. Several human and veterinary uses in 
traditional medicine are described for different parts and preparations based on this plant. 
Previous literature survey have demonstrated ethanomedical uses of different extracts as 
antimicrobial, anti-inflammatory, antidiarrheal, antihypertensive, and anticancer agents, 
among others, supporting some of its popular uses.  
 
Anti neoplastic activity   
Numerous cancer research studies have been conducted using traditional medicinal plants in 
an effort to discover new therapeutic agents that lack the toxic side effects associated with 
current chemotherapeutic agents Therefore the identification of active plant constituent is an 
essential component of modern phytochemistry and medical effects are not  necessarily 
restricted to a single plant chemical. The biological activity and clinical value of the whole 
plant, as in medicinal herbalism, is also being pursued. Despite their widespread use, 
however, less scientific assessment for anticancer effect for the isolated compound from the 
root extract has been conducted in most cases.53 
 It  has  been found  that  the anticancer studies  carried  out  in Jatropha gossypiifolia  have  
not  made  any  attempt  to  characterize  and  explore the active principles responsible for 
combating this dreadful disease. Though  ample  literatures on  therapeutic application of  
these  plants are  available  but  data  on  the  proximate  compounds  responsible  for the  
anticancer  activity  of  these  plants  are  very  scarce.  Considering their increasing 
recognition, the present study was undertaken to evaluate   the   anticancer   potential on root 
extract as well as the isolated compound to determine the inhibition in cell proliferation.54 
An attempt has been made in the present research, to assess the cytotoxicity on root extracts 
and fractions of Jatropha gossypiifolia on MCF-7 cell line. (Breast Cancer Cell line) and also 
to isolate the active compound from the potent fraction having highest anticancer activity 
with the same cell line. The isolated compound is also planned for spectral characterization 
by hyphenated techniques like FT-IR,1HNMR, GC MS and also subjecting the isolated 
compound for the in vitro anti-cancer activity on MCF-7 Cell line.  
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5. AIM & OBJECTIVE 
 
Aim 
To evaluate phytochemical and in vitro anti-cancer activity on roots of Jatropha 
gossypiifolia Linn  
 
Objective 
 To perform Soxhlet extraction on roots of Jatropha gossypiifolia 
 To evaluate preliminary phytochemical screening and in vitro anti-cancer 
activity of the extracts on Breast Cancer line (MCF-7) 
 To subject the active extract for fractionation in column chromatography in 
solvents from non-polar to polar by gradient elution.(n-hexaneto ethanol) 
 To evaluate the anticancer activity in fractions on Breast Cancer line (MCF-7). 
 To perform Preparative HPLC for the bio active fraction and isolate the pure 
compound  by observing the peak area , height and retention time. 
 To characterize the compound byFT-IR,1HNMR, GCMS and  interpret it to 
determine the structure. 
 To perform the docking studies for the isolated compound on breast cancer 
target protein human tankyrase 2.  
 To investigate Gene expression of isolated compound by RT PCR method. 
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6.SCHEME OF WORK 
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7.MATERIALS AND METHODS 
Collection of Plant 
The roots of Jatropha gossypiifolia were collected from Chennai, Tamil Nadu, India. 
The plant material was identified and authenticated by Botanist Dr.SasikalaEthirajulu, 
Research officer, CCRAS, Govt.of India, Chennai. The roots of Jatropha gossypiifolia were 
dried under shade, segregated, pulverized by a mechanical grinder and passed through a 40- 
mesh sieve.  
Preparation of extracts 
The dried powder of the root was extracted sequentially by hot continuous percolation 
method bySoxhlet apparatus, using chloroform and ethanol as solvent. The extracts were 
concentrated by using a rotary evaporator.55 
PRELIMINARY PHYTOCHEMICAL SCREENING 
The extracts obtained were subjected for phytochemical screening using standard procedure. 
The dried extracts were dissolved in sufficient amounts of respective solvents and tested for 
various constituents.56,57The results of the tests are mentioned in table 2. 
Carbohydrates 
Molisch’s test (General test): To the extract (2 – 3ml) few drops of α naphthol 
solution was added and then from the sides of the test tube concentrated H2SO4 was added 
drop wise. A violet ring formed at the junction of two liquids indicates the presence of 
carbohydrates. 
Fehling’s test: To a mixture of 1ml of Fehling’s A and 1ml Fehling’s B in a test tube 
equal volume of extract was added and heated in a boiling water bath for 5 – 10 min. A brick 
red precipitate indicates the presence of reducing sugars. 
Benedict’s test: Equal volume of Benedict’s reagent was mixed with the extract in 
the test tube and heated on a boiling water bath. Solution, which appears green, yellow or red, 
indicated the presence of reducing sugar. 
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Barfoed’s Test: Equal volume of Barfoed’s reagent was mixed with extract and 
heated for 1 -2 min. in boiling water bath and cooled. Red precipitate indicates the presence 
of monosaccharides. 
Aniline acetate test: The extract was boiled in a test tube and the filter paper soaked 
in aniline acetate was shown in the vapor. Filter paper turns pink confirming the presence of 
pentose sugars. 
Bial’sOrcinols Test: To the boiling Bial’s reagent few drops of extract was added. 
Appearance of green or purple color indicates the presence of pentose sugars. 
Seliwinoff’s Test: 3ml of seliwinoff’s reagent was heated with 1ml of extract in water 
bath for 1 – 2min. Formation of red color indicates the presence of hexose sugars (fructose). 
Tollen’sPhloroglucinoltest: 2.5ml of Con. HCl was mixed with 4ml of 0.5% 
Phloroglucinol and 1 – 2ml of extract. Appearance of yellow to red color on heating shows 
the presence of hexose sugar (galactose). 
Extract on treatment with Fehling’s and Benedict’s reagent and indicates the 
presences or absence of non-reducing sugars. Positive response towards reagent confirms the 
presence of non-reducing sugars and vice versa. 
Iodine Test: 3 ml of extract was mixed with few drops of Iodine solution. 
Appearance of blue colour indicates the presence of starch. 
Test for gums: Hydrolyzed extract with dilute HCl was mixed with Fehling’s or 
Benedicts reagents. Appearance of red color shows the presence of gums. 
Test for mucilage: Powdered material was treated with ruthenium red. A formation 
of red color indicates the presence of mucilage. 
Proteins 
Biuret Test:3ml of extract was added with 4% NaOH and few drops of 1% CuS04 
solution. Violet or pink colour formation indicates the presence of proteins. 
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Millon’s Test: The extract was mixed with Millon’s reagent. Formation of white 
precipitate at first which later turns to brick red on warming shows the presence of proteins. 
Ninhydrin test: 3ml of extract was heated with 3 drops of ninhydrin solution in 
boiling water bath for 10 min. Purple or bluish color appearance shows the presence of amino 
acids. 
Fats and Oils. 
Solubility Test: The solubility of extract was checked in various solvents. Oils are 
soluble in ether, chloroform and benzene and insoluble in alcohol and water. 
Saponification test: The concentrated extract was boiled with 25mlof 10% NaOH in 
boiling water bath for 30min and cooled. An excess of Na2S04 solution was added. Soap 
forms and rises to the top. filter. To the filtrate add H2S04. Evaporate. Collect the residue, it 
contain glycerol. Dissolve the residue in ethanol. With Ethanol solution, the following test 
was performed. 
To the Ethanol solution few drops of KHSO4, was added and heated. Pungent odour 
of acrylic aldehyde indicates the presence of fats. 
To the ethanol solution few drops of CuS04 and NaOH solution were added. 
Appearance of clear blue solution shows the presence of fats. 
Steroids   
Salkowski reaction: 2 ml of extract was mixed with 2 ml of chloroform and 2 ml of conc 
H2S04 through the sides of the test tube. After shaking, appearance of red colour in 
chloroform layer and green fluorescence in the acid layer shows the presence of steroid.  
Libermann – Burchard reaction (LB test): 2ml of the extract with chloroform was mixed 
with 1 – 2ml acetic anhydride and 2 drops of conc. H2S04 through the sides of the test tube. 
Appearance of red colour, then blue and finally green colour indicates the presence of steroid. 
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Libermann reaction: 3ml of the extract was mixed with 3ml acetic anhydride and heated 
gently and cooled. Few drops of Con. H2S04 were added through the sides of the test tube. 
Appearance of blue colour indicates the presence of steroids. 
Volatile oils 
Hydro & aqueous distillation of the drug material shows the presence of volatile oil 
and following test confirms the volatile oil. A drop of oil was placed on a filter paper. If the 
filter paper is not permanently stained with oil, presence of volatile oil is confirmed. 
Solubility test: The solubility of oil in 90% alcohol shows the presence of volatile oils. 
Glycosides  
Cardiac glycosides 
Baljet Test: Sodium picrate is added to the test drug. Appearance of yellow to orange 
colour shows the presence of cardiac glycosides. 
Legal test: To the extract 1ml of pyridine and 1ml sodium nitroprusside was added. 
Appearance of pink to red colour indicates the presence of cardiac glycosides. 
Keller Kiliani Test: To 2ml of extract, 0.5ml of glacial acetic acid, one drop of FeCl3and 
conc H2S04 were added. Appearance of reddish brown layer at the junction of two liquids 
indicates the presence of digitoxose sugar. 
Anthracene glycosides  
Borntrager’s test: 2ml of extract was boiled with 0.5ml of dil. H2SO4 and filtered. 
To the cold filtrate, equal volume of benzene or chloroform was added and the organic layer 
was separated and treated with few drops of ammonia solution. Appearance of pink or red 
shows the presence of anthraquinone glycosides. 
           Modified Borntrager’s test: 2 ml of extract was heated with few drops of dil. H2SO4 , 
FeCl3 , dil. HCl for 5 min on water bath. After cooling few ml of organic solvent was added 
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and shaken. The organic layer was separated and equal volume of dil. Ammonia solution was 
added. Appearance of pink or red colour shows the presence of C glycosides.   
Saponin glycosides 
Foam test: The drug powder or the extract was shaken vigorously with water. A 
persistent foam indicates the presence of saponin glycosides. 
Haemolytic test: To the extract or the drug powder, one drop of blood was added. 
Appearance of haemolytic zone indicates the presence of saponin glycosides. 
Cyanogenetic glycosides 
Grignard reaction or sodium picrate test:  A filter paper strip was soaked in 10% 
acetic acid, then in 10% sodium carbonate and dried. The moistened powdered drug was 
placed in a conical flask and closed with cork placing the filter paper strip below the cork. 
Appearance of brick red or maroon color in the filter paper indicates the presence of 
cyanogenetic glycosides. 
To the dry powder or the extract, a drop of 3% mercurous nitrate solution was added. 
Formation of metallic mercury indicates the presence of cyanogenetic glycosides. 
Coumarin glycosides    
The extracts made alkaline with dil. NaOH shows green or blue fluorescence 
indicating the presence of coumarin glycosides. 
Phenolic compounds 
To the extract, a few drops of FeCl3 solution were added. Appearance of deep blue to 
black color shows the presence of phenolic compounds. 
The extract was treated with dil. Iodine solution. Formation of transient red colour 
indicates the presence of phenolic compounds. 
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To the extract, a few drops of lead acetate solution were added. Formation of white 
precipitate shows the presence of phenolic compounds. 
The extract was treated with dil NH4OH and potassium ferricyanide solution. 
Appearance of red colour shows the presence of phenolic compounds. 
The extract was mixed with dil. HNO3 and formation of red to yellow colour indicates 
the presence of phenolic compounds. 
Flavonoids 
Shinoda test: The extract was treated with 0.5g of magnesium turnings and few drops 
of conc. HCl from the sides of the test tube. Appearance of pink colour shows the presence of 
flavonoids. 
To the extract, few drops of lead acetate solution were added. Formation of yellow 
precipitate indicates the presence of flavonoid.  
The extract was mixed with excess amount of sodium hydroxide solution. Appearance 
of yellow coloration indicates the presence of flavonoid. 
Alkaloids 
The extract was acidified with dil. HCl and filtered. The following tests were 
performed using the filtrate. 
Dragendroff’s test: To the filtrate, a few drops of Dragendroff’s reagent were added. 
Formation of orange brown precipitate shows the presence of alkaloids. 
Mayer’s Test: The filtrate was treated with few drops of Mayer’s reagent. Formation 
of cream coloured precipitate indicates the presence of alkaloids. 
Hager’s test: The filtrate was treated with few drops of Hager’s reagent. Appearance 
of yellow precipitate shows the presence of alkaloids. 
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8. BIOACTIVE GUIDED ISOLATION 
In vitro anticancer activity of Extracts 
MTT assay58,59 
In vitro cytotoxic effect on extractsof Jatropha gossypiifolia was evaluated by using MTT 
assay In brief, the trypsinized cells from T-25 flask were seeded in each well of 96-well flat-
bottomed tissue culture plate at a density of 5x103 cells/well in growth medium and cultured 
at 37°C in 5% CO2 to adhere. After 48hr incubation, the supernatant was discarded and the 
cells were pretreated with growth medium and were subsequently mixed with different 
concentrations of test compounds (0, 0.025, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5mg/ml) in triplicates to 
achieve a final volume of 100μl and then cultured for 48hr. The extract and fractions was 
prepared as 1.0 mg/ml concentration stock solutions in PBS. Culture medium and solvent are 
used as controls. Each well then received 5μl of fresh MTT (0.5mg/ml in PBS) followed by 
incubation for 2hr at 37°C. The supernatant growth medium was re-moved from the wells 
and replaced with 100μl of DMSO to solubilize the colored formazan product. After 30 min 
incubation, the absorbance (OD) of the culture plate was read at a wavelength of 572 nm on 
an ELISA reader, Anthos 2020 spectrophotometer. The percentage cell growth is determined 
and EC50 is determined.The term half maximal effective concentration (EC50) refers to the 
concentration of a drug, antibody or toxicant which induces a response halfway between the 
baseline and maximum after a specified exposure time. It is commonly used as a measure of 
drug's potency. 
 
ISOLATION BY COLUMN CHROMATOGRAPHY 
Ethanol extract was subjected for column chromatographic isolation and wet packing method 
was followed. Initially 3/4th of the column is filled with hexane and then silica gel (100 – 200 
mesh size) is added slowly to ensure uniform packing. 20gms of ethanol extract was 
chromatographed over a column of 400gms silica gel by gradient elution.  The column was 
developed by elution with hexane (100%) followed by hexane: pet ether (160:40, 150:50, 
100:100), pet ether (100%) and pet ether: chloroform (160:40, 150:50, 100:100), chloroform 
(100%) and chloroform: ethyl acetate (160:40, 150:50, 100:100), ethyl acetate (100%) and 
ethyl acetate : ethanol (160:40, 160:40, 150:50, 100:100) and finally ethanol 100%. The 
fractions were collected 200ml each. The yellowish green fractions were started eluting from 
chloroform (100%) and chloroform: ethyl acetate (160:40, 150:50, 100:100, and ethyl acetate 
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Preparative HPLC is used for the isolation and purification of valuable products in the 
chemical and Pharmaceutical industry as well as in biotechnology and biochemistry. For 
identification and structure elucidation of unknown compounds in synthesis or natural 
product chemistry it is necessary to obtain pure compounds in amounts ranging from one to a 
few milligrams.60 
 
Procedure 
Analytical HPLC  
Analytical HPLC was performed with a Cosmosil C-18 column (15.0mm×4.6 mm, 5μm) 
using a Gilson Model 576 pump. The mobile phase was Methanol: water = 90:10 containing 
0.1% TFA. Before delivering into the system, it was filtered through 0.45μm, and degassed 
using a vacuum. The analysis was carried out under isocratic conditions using a flow rate of 
1.0 mL/min at room temperature (25ºC). Chromatograms were recorded using a Shimadzu 
SPD-10A vp UV-VIS detector, with monitoring at 237nm. The injection volume was 20μL 
for analytical-size injections.  
Preparative HPLC  
Preparative HPLC was performed with a Gilson Model 576 pump and column (Cosmosil 
C18-AR-II, 20 mm × 250 mm, 5μm) using Methanol: Water = 90:10 containing 0.1% TFA as 
mobile phase at a flow rate of 5.4mL /min; UV-Vis detector, monitoring on 237nm. 
Chromatogram of isolated compound was concentrated by rotary evaporator and analyzed by 
analytical HPLC to check the purity prior to characterization.60 
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9. CHARACTERIZATION 
 
Instruments used for characterization: 
FTIR (Fourier Transform Infra-red Spectroscopy) is a sensitive technique particularly 
for identifying organic chemicals in a whole range of applications although it can also 
characterize some inorganics. Examples include paints, adhesives, resins, polymers, 
coatings and drugs. It is a particularly useful tool in isolating and characterizing 
organic contamination.  
NMR or nuclear magnetic resonance spectroscopy is a technique used to determine a 
compound’s unique structure. It identifies the carbon-hydrogen framework of an 
organic compound. Using this method and other instrumental methods including 
infrared and mass spectrometry, scientists are able to determine the entire structure of 
a molecule  
GCMS: 
Principle   of   GC  MS a   combination   of   two  different   analytical   techniques,   
Gas   chromatography  GC)  and Mass  Spectrometry (MS),  is  used  to  analyze  
complex organic and biochemical mixtures 61 The GC - MS instrument consists of 
two main components.  The  gas  chromatography  portion  separates different  
compounds  in  the  sample  into pulses  of  pure chemicals    based    on    their    
volatility    Oregon    State University, 2012)by flowing an inert gas (mobile phase), 
which  carries  the  sample,  through  a  stationary  phase fixed  in  the column. 
Spectra  of compounds  are  collected  as  they  exit  a  chromatographic column  by  
the  mass  spectrometer,  which  identifies  and quantifies  the  chemicals  according  
their  mass-to-charge ratio  (m/z).  These spectra can then  be  stored  on  the 
computer and analyze.  
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10. DOCKING OF ISOLATED COMPOUND 
 
Procedure: 
Glide Docking62 
 
 The process of docking a set of compounds (ligands) from a file to a PDB target that has a co 
crystallized ligand. The process involves preparing the protein, preparing the ligands, setting 
up a grid, and docking the compounds.Preprocessing is necessary because modeling requires 
3D, all-atom structures with hydrogens. 
 
Preparing the Protein 
 
1. Choose thetasks  Protein Preparation or Applications and then Protein Preparation Wizard. 
2. In the Import and Process tab, enter the PDB ID into the PDB text box, and click Import. 
3. Choose options for preprocessing the protein structure (other than the defaults).  
• If  waters in the active site is not needed , enter 0 in the Delete waters beyond text box. 
• If needed convert selenium atoms to sulfur, select Convert selenomethionines to 
methionines. 
4. Then Click Preprocess. 
5. Address any problems reported in the Protein Preparation in the Problems dialog box. 
• If the problems are far from the active site, select the Fill in options and Cap termini, and 
click Preprocess again. 
• If the problems are in or near the active site, run a Prime Refinement for the problem side 
chains and loops. 
6. Delete unwanted parts of the system (chains, solvent molecules, etc.) in the Review and 
Modify tab. 
7. Optimize the H-bond network in the Refine tab. 
8. Click Minimize to run a restrained minimization on the structure. 
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Preparing the Ligands 
 
1. Choose Tasks in that  Ligand Preparation or Applications and then LigPrep. 
2. Set Use structures from to File, and then click Browse to find and select your ligand file. 
3. If Epik is installed, under Ionization select Using: Epik. 
4. If the protein has a metal in the binding site, select Add metal binding states (requires 
Epik). 
5. Click Run to run the job. If the ligand file is large, distribute the job over multiple 
processors if possible. 
 
Generating the Receptor Grid 
1. Choose Tasks → Docking → Grid Generation or Applications → Glide → Receptor Grid 
Generation. 
2. Display the prepared receptor in the Workspace. 
3. Pick the ligand to define the grid center. 
4. Adjust the size of the active site in the Site tab to accommodate larger ligands, if necessary. 
5. Add any constraints in the Constraints tab. 
6. Pick any rotatable hydroxyl or thiol groups in the active site if such groups could rotate 
during docking. 
7. Add any excluded volumes to exclude atoms from regions other than the receptor. 
8. Start the grid generation job. 
 
Docking the Ligands 
 
1. Choose Tasks → Docking → Glide Docking or Applications → Glide → Ligand Docking.  
2. Specify the receptor grid to use. 
3. Select the docking precision: 
• HTVS for initial screen of millions of compounds (shows limited conformational search but 
fast) 
• SP for thousands of compounds (better coverage of conformational space) 
• XP for tens or hundreds of compounds (high accuracy on docked poses) 
4. If XP is selected, select Write XP descriptor information if you want to visualize 
interaction terms. 
Docking Of Isolated Compound 
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5. Select Add Epik state penalties to docking score, if Epik was used in ligand preparation 
(especially for metalloproteins). 
6. Specify the ligand file to use, in the Ligands tab. 
7. If  want to set up constraints to a reference ligand core or calculate RMSD to this core, you 
can do this in the Core tab. 
8. Select the receptor constraints you want to use in the Constraints tab, and supply any 
required information. 
9. If the ligands are very flexible, apply constraints on ligand torsions in the Torsional 
Constraints tab, to reduce the torsional degrees of freedom. 
10. Set the number of poses per ligand and total number of poses in the Output tab. 
11. Use post-docking minimization to improve pose geometries if needed. 
12. Select Write per-residue interaction scores for residues within N Å of grid center if you 
want to examine interactions of ligand poses with the receptor, and set the cutoff distance. 
13. Run the job. If the ligand file is large, distribute the job over multiple processors if 
possible. 
 
Examining Poses 
1. Import the pose file jobname_pv.mae into Maestro. Ensure that the option For pose viewer 
files, turn on pose viewing is selected. 
2. In the View Poses panel, turn on display of H-bonds and contacts. If you wrote out per-
residue interaction scores, select Display in the Per-residue interactions section. 
3. Use the LEFT ARROW and RIGHT ARROW keys to step through the poses, and examine 
their interactions with the receptor. 
4. After finishing examining poses, right-click on the receptor entry in the Project Table and 
choose Unfix to exit the pose viewing mode. 
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11. IN VITRO ANTICANCER ACTIVITY OF ISOLATED COMPOUND 
 
In vitro cytotoxic effect on extractsofJatrophagossypiifolia was evaluated by using MTT 
assay against MCF -7 cell line. MCF cells were purchased from NCCS Pune. In brief, the 
trypsinized cells from T-25 flask were seeded in each well of 96-well flat-bottomed tissue 
culture plate at a density of 5x103 cells/well in growth medium and cultured at 37°C in 5% 
CO2 to adhere. After 48hr incubation, the supernatant was discarded and the cells were 
pretreated with growth medium and were subsequently mixed with different concentrations 
of test compounds (0.1µg, 1µg, 10µg and 100µg) in triplicates to achieve a final volume of 
100μl and then cultured for 48hr. The extract and fractions was prepared as 1.0 mg/ml 
concentration stock solutions in PBS. Culture medium and solvent are used as controls. Each 
well then received 5μl of fresh MTT (0.5mg/ml in PBS) followed by incubation for 2hr at 
37°C. The supernatant growth medium was re-moved from the wells and replaced with 100μl 
of DMSO to solubilize the colored formazan product. After 30 min incubation, the 
absorbance (OD) of the culture plate was read at a wavelength of 572 nm on an ELISA 
reader, Anthos 2020 Tamoxifen was used as the standard drug and percentage growth and 
GI50 was determined.58,59, 63 
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12. GENE EXPRESSION 
 Methodology 
Cell culture and treatment64 
1. The MCF-7 breast cancer cell line was purchased from NCCS Pune. The MCF-7 cells 
were grown in DMEM medium supplemented with 10% fetal bovine serum and 
antibiotics as mentioned earlier. For the Real time PCR assay, the cells were grown in 
25 cm ×25 cm ×25 cm tissue culture flasks containing DMEM medium as culture 
medium supplemented with 10% FCS, 100 U/ml penicillin, 100 μg/ml streptomycin 
(GIBCO) and grown at 37°C under a humidified atmosphere of 95% air and 5% CO2. 
Cells were regularly passaged and maintained before experiments. 
 
2. When the cell density in a culture flask reached 70-80% confluence, they were 
trypsinized and seeded in 6-well plates at a density of 300000 cells per well in 1000 
μL and incubated for 24 hours at CO2 incubator. 
 
3. Next day, test item was prepared as 100 mg/ml stock by adding directly in to the 
DMSO. The working stock of 2X (160, 80 and 40, 60 ug/ml) concentration was added 
to the cells in 1000μL volume and the final concentration range were: 80, 40 20, 100 
ug/ml .plate was further incubated for 48 hours in the CO2 incubator. 
 
RNA isolation -RNeasyMiniprep kit from Qiagen 
• The Total RNA is extracted from the treated cells samples   
• RNA Later preserved rat liver samples  
• Use the protocol from the attached book let page number 38-44. 
• Determination of RNA purity and concentration 
The final preparation of total RNA is essentially free of DNA and proteins and has a 260/280 
ratio 1.9. 
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High Capacity cDNA Reverse 
Table 2.kit components  
 
 
 
 
 
Transcription Kits: 
Kit Features Use the kit for: 
• Quantitatively converting up to 2 μg (for a 20-μL reaction) of total RNA to cDNA 
 • Generating single-stranded cDNA suitable for quantitative PCR applications 
• Generating single-stranded cDNA suitable for short- or long-term storage 
 
High Capacity cDNA Reverse Transcription Kit, 200 reactions (Part Number: 4374966) 
 
Kit Storage Store all kit components at –15 to –25 °C 
Preparing the 2✕Reverse Transcription Master Mix: 
To prepare the 2✕RT master mix (per 20-μL reaction) 
  
 
 
 
 
 
10✕ RT Buffer, 1.0 mL 1 tube 
10✕ RT Random Primers 1 tube 
25✕dNTP Mix (100 mM) 1 tube, 0.2 mL 
MultiScribe™ Reverse 
Transcriptase, 50 U/μL 
2 tubes ,0.1ml 
 
RNase Inhibitor, 100 μL 
 
2 tubes 
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Table 3.  Volume of Components for preparing Reverse Transcription Master Mix  
1. Allow the kit components to thaw on ice. 
 
 
 
 
 
 
 
 
 
 
 
 
2. Referring to the tableabove, calculate the volume of components needed to prepare the 
required number of reactions. 
Note: Prepare the RT master mix on ice. 
3. Place the 2✕ RT master mix on ice and mix gently. 
 
Kit with RNase Inhibitor 
To prepare the cDNA RT reactions: 
 
1. Pipette 10 μL of 2✕ RT master mix into each well of a 96-well reaction plate or individual 
tube. 
2. Pipette 10 μL of RNA sample into each well, pipetting up and down two times to mix. 
3. Seal the plates or tubes with optical Adhesive sheet. 
4. Briefly centrifuge the plate or tubes to spin down the contents and to eliminate any air 
bubbles. 
5. Place the plate or tubes on ice until you are ready to load the thermal cycler.  
 
 
 
 
 
Component 
 
Volume/Reaction 
(μL) 
 
10✕ RT Buffer 2.0 
25✕dNTP Mix (100 mM) 0.8 
10✕ RT Random Primers 2.0 
MultiScribe™ 
Reverse Transcriptase 1.0 
RNase Inhibitor 1.0 
Nuclease-free H2O  3.2 
Template 10 
Total Volume (ul) 20 
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Table 4. Preparation of  c DNA RT reaction 
 
Program: 
1. Set the reaction volume to 20 μL. 
2.  Load the reactions into the thermal cycler. 
3. Start the reverse transcription run. 
 
Real Time PCR 
• A real-time PCR reaction mixture of 20 µl prepared. 
• All reactions were performed in duplicate and Non template control (negative 
control) contained no template DNA. The PCR conditions were as follows: 
Table 5.Contents and volume of Real Time PCR reaction mixture 
S. No       Contents Volume (µl) 
1 SYBR Green mix (2x)       10 µl 
2 Forward primer       0.6 µl 
3 Reverse primer      0.6 µl 
4 Template (c DNA)       1 µl 
5 Sterile water       7.8 µl 
Total      20 µl 
 
End of the rtPCR reaction the samples were stored in -20’C  
 
 
 Step 1 Step 2 Step 3 
 
Step 4 
 
Temperature(°C) 25 37 85 4 
Time 10 min 120 min 5 min ∞  
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Table 6. PCR Conditions 
 
 
 
 
 
 
 
 
 
 
 
Steps 
Temperature  
( in Deg) 
Time  
Denaturation 95°C 20 Seconds 
Annealing 95°C 03 seconds 
Extension 60 30 seconds 
Repeat  40 cycles 
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13. ACUTE TOXICITY STUDY OF AN ISOLATED COMPOUND  
 
procedure 
The acute toxicity studyof an isolated compound was carried out by using the software 
OSIRIS which is used to determine the toxicity risk such as mutagenic, tumorigenic ,irritant 
,reproductive effective , clog p, solubility, molecular weight , TPSA, drug likeness and drug-
score for the specific structure of the compound.  
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14. RESULTS AND DISCUSSION 
 
14.1 Extractive values  
Table 7.Extractive values of Jatropha gossypiifolia 
Solvent Color Consistency % Yield 
Chloroform Yellowish brown Sticky 17.2 
Ethanol Reddish brown Sticky  35.5 
 
14.2 Phytochemical screening 
Table 8.Phytochemical Screening on root extracts of Jatropha gossypiifolia 
S.N Name of the test Chloroform Ethanol 
1. LibermanBurchard (for terpenes& steroid)       +      - 
2. Salkowski (for steroid &terpenes)       +      - 
3. Fixed oils and fats.       -      - 
4. Mayer’s (for alkaloids)       +      - 
5. Molisch (for carbohydrates)       -      - 
6. Fehlings (for carbohydrates)       -      - 
7. Baljet’s test for glycosides      +      + 
8. Legal,s test for glycosides      +      + 
9. Test for Phenolics (FeCl3)      -      + 
10. Shinoda (for flavonoids)      -      + 
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Table 9: Thin Layer Chromatography of Fractions from Column Chromatogrpahy 
 
 
 
 
 
 
 
 
 
 
 
Fractions Solvent system No of Spots Rf value 
Chloroform fraction Hexane: Chloroform 
(9:1),(8:2), (7:3) 
      3 0.7,0.6,0.5 
 
Chloroform:ethyl 
acetate 
Hexane: Ethyl acetate 
(9:1),(8:2), (7:3) 
Chloroform:ethylacetate 
(9:1, (8:2), (7:3) 
      4 0.6,0.5,0.3,0.2 
Ethyl acetate : 
Ethanol 
Chloroform: Methanol 
(9:1),(8:2), (7:3) 
Chloroform: ethyl acetate 
(9:1),(8:2), (7:3) 
     3 0.7,0.6,0.5 
 
Ethanol (100%) Chloroform: Methanol 
(9:1),(8:2), (7:3) 
Chloroform: ethyl acetate 
(9:1),(8:2), (7:3) 
    3 0.7,0.6,0.5 
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 Thin Layer Chromatography 
 
Fig 7 .Thin Layer Chromatography of fractions 
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15. MTT ASSAY 
 MTT ASSAY OF EXTRACTS 
 
Table 10. Effect of Cytotoxicity on chloroform extract of Jatropha gossypiifolia 
on MCF-7 Cell Line 
Concentration 
mg/ml 
 
Vehicle 
 
Chloroform extract 
 Absorbance Percentage 
growth 
Absorbance Percentage 
growth 
0 1.05800 100.0000 1.05800 100.0000 
0.025 1.04560 98.82798 1.05300 99.52741 
0.05 1.02370 96.75803 0.83300 78.73346 
0.1 099825 94.35255 0.68400 64.65028 
0.2 098275 92.88752 0.52203 49.34121 
0.3 0.97400 92.06079 0.52012 49.16068 
0.4 0.97125 91.80057 0.51475 48.65312 
0.5 0.95650 90.40643 0.52475 49.59830 
 
                                                EC50: 0.00018 mg/ml 
Fig 8. Dose Vs Response curve of Chloroform Extract on MCF-7 Cell line 
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Table 11. Effect of Cytotoxicity on ethanol extract of Jatropha gossypiifolia 
on MCF-7 Cell Line 
 
Concentration 
mg/ml 
 
Vehicle 
 
Ethanol extract 
 Absorbance Percentage 
growth 
Absorbance Percentage 
growth 
0 1.05800 100.0000 1.05800 100.0000 
0.025 1.04560 98.82798 0.78225 73.93667 
0.05 1.02370 96.75803 0.75222 71.09830 
0.1 099825 94.35255 0.70518 66.65217 
0.2 098275 92.88752 0.56840 53.72401 
0.3 0.97400 92.06079 0.52187 49.32609 
0.4 0.97125 91.80057 0.37820 35.74669 
0.5 0.95650 90.40643 0.30120 28.46881 
 
EC50: 0.00055 mg/ml 
 
Fig 9.Dose vs Response curve of Ethanolic Extract on MCF-7 Cell line  
 
 
 
Fig 10. Extracts treated against MCF-7 cell line 
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Chloroform Extract : (0.5mg/ml)                        Ethanol Extract : (0.5mg/ml)                                           
 
 
 
 
 
 
 Discussion 
 
Table no 10 & 11 depict the percentage growth of MCF-7 cells in chloroform and ethanol 
extract treated against MCF-7 cell line was found to be 49.59 and 28.46 respectively. The 
EC50 value of chloroform and ethanol extract was found to be 0.00018 & 0.00055mg/ml 
respectively. This clearly indicates that ethanol extract have better anticancer activity on 
MCF-7 cell line than the chloroform extract. As it was found in preliminary phytochemical 
screening, (table no 8) the ethanol extract shows the presence of flavonoids and phenolic 
compounds, the better anticancer activity of ethanol extract may be due to the presence of 
these active compounds. 
The percentage growth of MCF-7 cells at 0.5mg /ml of chloroform and ethanol extract 
49.59830&28.46881 respectively 
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MTT ASSAY OF FRACTIONS 
 
Table12. Cytotoxic effect of  Chloroform fraction of Jatropha gossypiifolia 
on MCF-7 Cell Line 
 
Concentration 
mg/ml 
 
Vehicle 
 
Chloroform fraction            
(Fraction1) 
 Absorbance Percentage 
growth 
Absorbance Percentage 
growth 
0 1.05800 100.0000 1.05800 100.0000 
0.025 1.04560 98.82798 0.48600 45.93573 
0.05 1.02370 96.75803 0.42725 40.38280 
0.1 099825 94.35255 0.41275 39.01229 
0.2 098275 92.88752 0.28875 27.29206 
0.3 0.97400 92.06079 0.28625 27.05577 
0.4 0.97125 91.80057 0.26075 24.64556 
0.5 0.95650 90.40643 0.25950 24.52741 
 
EC50: 0.00082 mg/ml 
 
Fig 11. Dose vs Response curve of Fraction 1 on MCF-7 Cell line 
 
 
 
 
Results And Discussion Of MTT Assay 
 
Department of pharmaceutical chemistry,MMC Page 51 
 
Table 13. Cytotoxic effect of Chloroform: ethyl acetate (fraction 2) of  
Jatropha gossypiifolia on MCF-7 Cell Line 
 
Concentration 
mg/ml 
 
Vehicle 
 
Chloroform:Ethylcaetate           
(Fraction2) 
 Absorbance Percentage 
growth 
Absorbance Percentage 
growth 
0 1.05800 100.0000 1.05800 100.0000 
0.025 1.04560 98.82798 0.99975 94.49433 
0.05 1.02370 96.75803 0.94450 89.27221 
0.1 099825 94.35255 0.86750 81.99433 
0.2 098275 92.88752 0.77575 73.41682 
0.3 0.97400 92.06079 0.71909 67.96692 
0.4 0.97125 91.80057 0.58050 54.86767 
0.5 0.95650 90.40643 0.51982 49.13233 
 
EC50:  0.1728 mg/ml 
 
Fig12. Dose response curve for Chloroform: ethyl acetate fraction (2) on MCF-7 cell 
line. 
 
 
 
 
 
Results And Discussion Of MTT Assay 
 
Department of pharmaceutical chemistry,MMC Page 52 
 
Table14. Effect of Cytotoxicity on ethyl acetate: ethanol (fraction 3) of Jatropha 
gossypiifolia on MCF-7 Cell Line 
 
Concentration 
mg/ml 
 
Vehicle 
 
Ethyl acetate :ethanol             
(Fraction3) 
 Absorbance Percentage 
growth 
Absorbance Percentage 
growth 
0 1.05800 100.0000 1.05800 100.0000 
0.025 1.04560 98.82798 0.95000 89.79206 
0.05 1.02370 96.75803 0.78400 74.10208 
0.1 099825 94.35255 0.71475 67.55671 
0.2 098275 92.88752 0.65200 61.62571 
0.3 0.97400 92.06079 0.48500 45.84121 
0.4 0.97125 91.80057 0.39375 37.21645 
0.5 0.95650 90.40643 0.39050 36.90926 
 
EC50: 0.00028 mg/ml 
Fig13. Dose response curve for ethyl acetate: ethanol fraction (3) on MCF-7 cell line 
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Table 15.Effect of Cytotoxicity on ethanol 100% (fraction 4) of  
Jatropha gossypiifolia on MCF-7 Cell Line 
 
Concentration 
mg/ml 
 
Vehicle 
 
Ethanol (100%)             
(Fraction4) 
 Absorbance Percentage 
growth 
Absorbance Percentage 
growth 
0 1.05800 100.0000 1.05800 100.0000 
0.025 1.04560 98.82798 0.33575 31.73440 
0.05 1.02370 96.75803 0.28225 26.67769 
0.1 099825 94.35255 0.26450 25.00000 
0.2 098275 92.88752 0.18800 17.76938 
0.3 0.97400 92.06079 0.18350 17.34405 
0.4 0.97125 91.80057 0.18150 17.15501 
0.5 0.95650 90.40643 0.15500 14.65028 
 
EC50: 0.00087 mg/ml 
 
 
Fig 14.Dose response curve of ethanol fraction (4) on MCF-7 cell line  
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 DISCUSSION 
Table 12 to 15& Fig 11 to 14 of dose response curves depict the in vitro anticancer activity 
from fractions (1 to 4) from column chromatography on MCF-7 cell line. The fraction 4 
(Ethanol 100%) shows the good anticancer activity compared to other fractions against MCF-
7 cell line. The percentage growth of MCF-7 cells in fraction (1 -4) was found to be 24.527, 
49.132, 36.909, 14.650 respectively. The EC50 value was found to be for fractions (1 to 4) 
was found to be 0.00082, 0.1728, 0.00028, 0.00087mg/ml respectively.The cytotoxic effect 
on maximum concentration 0.5mg/ml of fractions treated against MCF – 7 cells was seen in 
fig 15. 
This clearly indicates that fraction (IV) shows good anticancer activity against MCF-7 cell 
line when compared to other 3 fractions.Hence fraction (1V)is an active fraction. 
 
Fig15. Fractions treated against MCF-7 cell line  
Chloroform fraction: (0.5mg/ml)Chloroform:ethyl acetate: (0.5mg/ml)       
 
Ethyl acetate: ethanol: (0.5mg/ml)                         Ethanol 100% : (0.5mg/ml) 
                                                                                                                                                                                
 
 
 
 
 
Ethyl acetate: ethanol: (0.5mg/ml)                         Ethanol 100% : (0.5mg/ml) 
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16. RESULTS AND DISCUSSION OF ISOLATION & PURIFICATION 
 
Bio active fraction (Ethanol 100%)  was subjected for isolation and purification by 
Preparative HPLC.  In this study, compound isolation is performed effectively by preparative 
HPLC  
UV SPECTROSCOPY 
 Initially UV Spectrum was carried out to find out the wavelength of maximum absorbance 
(λmax). The λmaxwasfound to be 237nm. 
 
Fig: 16.  UV Visible Spectrum of fraction 1V 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Analytical HPLC 
The Analytical HPLC was carried out at the same 237nm to find out the number of peaks and 
also to determine the single peak which has good retention time and higher peak area and 
height.The analysis was carried out under isocratic conditions using a flow rate of 1.0 
mL/min at room temperature (25ºC). In Fig:16. Of Analytical HPLC shows that Peak 1 has 
retention time of 2.645 with height 23359 and area of 89.703. The peak 1 was selected for 
isolation by Preparative HPLC 
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Fig 17. HPLC analysis of fraction 1V 
 
 
 
Preparative HPLC 
The peak 1 was selected for isolation by preparative HPLCusing Methanol: Water = 90:10 
containing 0.1% TFA as mobile phase at a flow rate of 5.4mL /min. The isolated peak was 
collected in 50ml centrifuge tubes. Totally 250ml of fraction has been collected. Hence the 
single purified compound was separated effectively. Analytical HPLC was also done for the 
isolated compound to confirm its purity prior to characterization. 
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Fig 18 . HPLC Analysis after separation by preparative HPLC 
 
 
 
Sodium hydroxide test: 
The little amount of isolated compound is dissolved in water, warmed and filtered. 10% 
aqueous sodium hydroxide is added to 2 ml of this solution. This produces a yellow 
coloration. A change in color from yellow to colorless on addition of dilute hydrochloric acid 
is an indication for the presence of flavonoids.65 
The isolated compound was subjected to qualitative analysis for the test of flavonoid and 
phenolic compounds. The compound gives the positive test for flavonoid. 
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17. RESULTS OF CHARACTERIZATION  OF ISOLATED 
COMPOUND 
FT- IR spectra of isolated compound. 
 
Fig 19.  FT- IR Spectrum of an Isolated Compound 
 
 
 
2977 cm-1 (Aromatic CH stretching), 1730 cm-1,C=O (Carbonyl group of Chromene ring), 
1637cm -1(Aromatic C=C). 
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GC MS Spectrum of Isolated compound 
Fig 20.GC MS Spectrum of Isolated compound 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
The Fig20.Shows the gas chromatogram of isolated compound. It is clearly seen that high RT 
value of 17.12 and the corresponding molecular weight of 222 m/z which is the flavonoid 
belongs to the class flavone  with the molecular formula C15H10O2 
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NMR Spectrum 
Fig21.1H NMR Spectrum of Isolated compound 
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Table 16.1H NMR spectrum of isolated compound: 
Type of Proton δ Value Peak No of Protons 
Chromene CH 6.8 Singlet 1 
a) Aromatic - CH 7.514 - 7.583   Multiplet 5 
b) Aromatic -  CH 7.921 – 7.946 Doublet  2 
ChromeneAr – CH 7.409 – 7.441 
& 7.687 -7.722 
Triplets 2 
Methanol  δ 3.5 Singlet 1 
 
Number of protons = 10 
Molecular formula: C15H10O2 
 
 
Fig 22. Structure of flavone 
 
 
 
 
 
 
Results Of Docking Of An Isolated Flavone 
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18. RESULTS OF DOCKING OF AN ISOLATED FLAVONE 
Fig23  .  Docking pose 
 
 
 
Fig24 . Ligand receptor intraction 
 
Discussion: 
The amino acid residue 1032 Glycine and 1068 Serine forms hydrogen bonding with oxygen 
atom in carbonyl group of chromene ring. Pi bond interaction was formed by tyrosine 1071 in 
chromene ring which is shown in Fig 23. The hydrogen bonding and the Pi bond interactions 
lead to a good docking score of -9.538.Tankyrases are ADP-ribosyltransferases that play key 
roles in various cellular pathways, including the regulation of cell proliferation, and thus, they 
are promising drug targets for the treatment of cancer. Flavones have been shown to inhibit 
tankyrases and we report here the discovery of more potent and selective flavone 
derivatives.66 
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19. IN VITRO ANTI-CANCER ACTIVITY OF FLAVONE ON MCF -7 
CELL LINE 
Table 17.In vitro anti-cancer activity of flavone on MCF -7 cell line 
 
 
 
Fig 25.Percentage growth of MCF-7 Cell  
  
  
 
 
 
 
 
Compounds PERCENTAGE GROWTH 
GROWTH INHIBITON IN 
mg 
1000µg 100µg 10µg 1µg 0.1µg GI50 TGI LC50 
Tamoxifen -29 0 49 89 80 9.2 100.0 100.0 
Flavone -7 40 68 92 92 43.48 100.0 100.0 
Average           26.4 100.0 100.0 
In Vitro Anti-Cancer Activity Of Flavone  
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Fig 26.Comparision of GI50with the standard tamoxifen 
 
Fig 27.Isolated compound treated against MCF-7 Cell line 
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DISCUSSION 
Table 11 shows that at 100µg of isolated compound flavone, the percentage growth of MCF-
7 cells was found to be 40. Flavone exhibits good anticancer activity compared to standard 
Tamoxifen, which shows dramatic decrease in percentage growth with 0 at 100µg. As 
discussed earlier in the introduction, the chemical components of medicinal plants mainly 
possess antioxidant properties that contribute to their anticancer potential. Flavones, 
isoflavones, flavonoids, anthocyanins, coumarins, lignans, catechins, andisocatechins are the 
major classes of bioactive constituents responsible for the antioxidant action.15Flavonoids 
may act at the different development stages of malignant tumors byprotecting DNA against 
oxidative damage, inactivating carcinogens, inhibiting the expressionof the mutagenic genes 
and enzymes responsible for activating procarcinogenicsubstances,and activating the systems 
responsible for xenobiotic detoxification.17Hence the isolated compound flavone shows good 
anticancer activity on MCF-7 cell lines. 
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            20. GENE EXPRESSION RESULTS 
Table 18. Calculation procedure for MNE 
 
 
2 
 Threshold for SEM in % 20.0 
 
Well Description CT of Target Gene 
CT of 
Reference 
Gene Actin 
Normalized 
Expression 
 
 
      
  Vehicle control 
33.39 26.73 2.51E-03 
   33.39 26.93 2.86E-03 
   
RPMMC- 20 µg/ml 
27.32 24.39 3.76E-02 
   27.32 24.29 3.53E-02 
   RPMMC- 40 µg/ml 
28.47 26.15 5.23E-02 
   28.49 26.44 6.24E-02 
   
RPMMC- 80 µg/ml 
27.32 26.06 1.10E-01 
   27.32 26.05 1.09E-01 
  
Table 19.Mean of duplicates 
Mean of duplicates 
  
Description 
Mean 
Normalized 
Expression 
SE of Mean 
Normalized 
Expression 
SE of Mean 
Normalized 
Expression in % 
 
 
 
 
    
 
 Vehicle control 2.68E-03 1.72E-04 6.42 
  
      RPMMC- 20 
µg/ml 3.64E-02 1.13E-03 3.10 
  
      RPMMC- 40 
µg/ml 5.71E-02 5.43E-03 9.51 
      
      
RPMMC- 80 
µg/ml 1.10E-01 3.90E-04 0.36 
   
 
 
 
 
 
 
 
 
Gene Expression Results 
 
Department of pharmaceutical chemistry,MMC Page 67 
 
Fig28. MCFCapase3 gene normalized expression cells treated with isolated compound 
 
 
 
 
 
 
 
 
 
 
 
 
 
J 
 
Fig 29. Real time PCR amplicon agarose Gel electrophoresis 
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 DISCUSSION  
The results of gene expression shows that at 80µg/ml there was an increase in the activity of 
caspase – 3 activity when compared to control gene. The isolated compound, flavone induces 
apoptosis in MCF-7 cells through caspase -3 activity in a dose dependent manner as show in 
fig28.The previous study supports for our present work that the presence of flavonoids can 
suppress the cancer cells. Several natural compounds with anticancer effects can induce 
apoptosis of tumor cells.67 
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21. TOXICITY STUDY OF AN ISOLATED COMPOUND 
 
Fig30 . Isolated compound showing Toxicity Risks 
 
 
 DISCUSSION 
The toxicity risk such as mutagenic, tumorigenic ,irritant ,reproductive effective , clog p, 
solubility, molecular weight , TPSA, drug likeness and drug-score for the specific structure of 
the isolated compound flavone was determinedfrom the above fig30.It was found that the 
compound is mutagenic in nature. The other parameters are found to be safe in nature . 
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22. SUMMARY AND CONCLUSION 
The chloroform and ethanol extracts was prepared from the dried powdered roots of Jatropha 
gossypiifoliaby hot continuous percolation method using soxhletapparatus.The extracts was 
subjected to preliminary phytochemical screening and was found that, secondary metabolites 
such as steroids, alkaloids, glycosides, flavonoids and phenolic compounds. It was found that 
ethanol extract shows the presence of flavonoids and phenolic compounds and it is absence in 
chloroform extract. 
 
Bio guided Isolation   
In vitro anticancer activity 
The chloroform and ethanol extract was subjected to in vitro anticancer activity on MCF – 7 
cell line. The ethanol extract shows better anti-cancer activity than chloroform extract with 
the percentage growth of 28.46 on MCF –7cells. Since the present scheme of work is 
bioguided isolation, the active extract (ethanol extract) was selected for isolation by column 
chromatography. 
 
Isolation by column chromatography 
Ethanol extract was subjected to column chromatography isolation by gradient elution 
technique. The yellowish green fraction was started eluting fromfractions(chloroform 100%), 
chloroform: ethylacetate (160:40), (150:50), (100:100) and ethyl acetate 100%. The brown 
colour fraction was started eluting from fractions (ethylacetate: ethanol) and ethanol 
100%.TLC was determined for the above fractions. The fractions with the same Rfvalue were 
mixed to contain totally of 4 fractions. Fraction 1 (chloroform fraction), fraction 2 
(chloroform: ethylacetate), fraction 3 (ethyl acetate: ethanol)and fraction 4 (ethanol 100%). 
 
In Vitro anticancer activity of fractions 
All the 4 fractions were subjected to anticancer activity on MCF – 7 cell lines. The fraction 4 
(Ethanol 100%) shows the good anticancer activity compared to other fractions against MCF 
-7 cell line. The percentage growth of MCF-7 cells in fraction (1 -4) was found to be 24.527, 
49.132, 36.909, 14.650 respectively. The EC50 value was found to be for fractions (1- 4) was 
found to be 0.00082, 0.1728, 0.00028, 0.00087mg/ml respectively.  
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This clearly indicates that fraction (4) shows good anticancer activity against MCF-7 cell line 
when compared to other 3 fractions. 
 
Isolation and Purification of fraction byPreparative HPLC  
Ethanol 100% (Fraction 4) is subjected for isolation and purification by Preparative HPLC.  
In this study, compound isolation is performed effectively by preparative HPLC. Initially UV 
Spectrum was carried out to find out the wavelength of maximum absorbance (λmax). The 
λmaxwasfound to be 237nm as shown in Fig 16.The Analytical HPLC was carried out at the 
same 237nm. The analysis was carried out under isocratic conditions using a flow rate of 1.0 
mL/min at room temperature (25ºC). In Fig:17. The Analytical HPLC shows that Peak 1 has 
retention time of 2.645 with height 23359 and area of 89.703. The peak 1 was selected for 
isolation by Preparative HPLC. The peak 1 was selected for isolation by preparative HPLC 
using Methanol: Water = 90:10 containing 0.1% TFA as mobile phase at a flow rate of 5.4mL 
/min. Hence the single purified compound was separated effectively. The isolated compound 
was subjected to qualitative analysis for the test of flavonoid and phenolic compounds. The 
compound gives the positive test for flavonoid. 
 
Characterization of isolated compound 
FT- IR spectra of isolated compound shows that, 2977 cm-1 (Aromatic CH stretching), 
1730cm-1,C=O (Carbonyl group of Chromene ring), 1637cm -1(Aromatic C=C). GC MS 
Spectrum of isolated compoundFig 20. Shows that high RT value of 17.12 and the 
corresponding molecular weight of 222 m/z which is a flavone with the molecular formula 
C15H10O2.1H NMR spectrum of flavone was found to have Aromatic CH at δ7.514 - 7.583 
and δ7.921 – δ7.946, multiplets. Chromene CH, δ6.8,singlet. ChromeneAr – CH, 7.409 – 
7.441. & 7.687 -7.722,triplets. Hence the isolated compound was found to be flavone. 
 
 
 
Docking Study of isolated compound  
The crystal structure of human tankyrase 2 in complex with flavone has shown good 
interaction with the receptor protein with the docking score of -9.538. The interaction with 
receptor was seen at the carbonyl carbon of chromene ring and the unsaturated part of 
chromene ring.  
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In vitro anticancer activity of flavone.  
In vitro anticancer activity of flavone was determined by MTT assay.At 100µg of isolated 
compound flavone, the percentage growth of MCF-7 cells was found to be 40. Hence flavone 
exhibits good anticancer activity compared to standard Tamoxifen, which shows dramatic 
decrease in percentage growth with 0 at 100µg.  
 
Gene Expression of flavone by RT PCR 
The results of gene expression show that at 80µg/ml there was an increase in the activity of 
caspase – 3 activity when compared to control gene. The isolated compound, flavone induces 
apoptosis in MCF-7 cells through caspase -3 activity in a dose dependent manner as show in 
Fig28.The previous study supports for our present work that the presence of flavonoids can 
suppress the cancer cells.   
 
Toxicity study of isolated compound 
The toxicity risk such as mutagenic, tumorigenic,irritant, reproductiveeffective, clog p, 
solubility, molecular weight , TPSA, drug likeness and drug-score for the specific structure of 
the isolated compound flavone was determined by using a software OSIRIS. It was found that 
the compound is mutagenic in nature. The other parameters were found to be safe. 
 
 
Conclusion 
The conclusion of the study present study is the ethanol extract and ethanol fraction of 
Jatropha gossypifolia (root) from column chromatography is proved to have antineoplastic 
activity. The flavone which is isolated from ethanol fraction is proved to be an effective 
antineoplastic agent .against MCF-7 cell line. 
 
Future Scope 
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23.Future Scope 
 Jatropha gossypifolia is proved to be potential anticancer drug. More research should 
be carried out to evaluate the in vivo anticancer activity on the extracts and isolated 
compound from this plant. 
 
 Apart from anti-cancer activity there is other pharmacological activity for this plant 
like neuropharmacological activity, hepatoprotective activity. Research should be 
carried out to find out the active principles involved in these activities.    
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